Archives

10/7/2010 - SciQuest e–Procurement Expands Access to Axenia BioLogix Products

8/1/2010 - Axenia BioLogix Supports Homeless Veterans, Fosters Broad Employee Volunteerism

7/26/2010 - Axenia BioLogix Launches New Partnership with UCSF Cell Culture Facilities

7/1/2010 - International Serum Industry Association Elects New Board of Directors; Axenia BioLogix's CEO Reappointed as Chief Financial Officer

6/30/2010 - Axenia BioLogix Announces New Alliance with University of California

 

Get Adobe Reader

 

News

Back to News
7/26/2010 - Axenia BioLogix Launches New Partnership with UCSF Cell Culture Facilities

Dixon, CA Axenia BioLogix, an innovative cell culture supplier serving the global industrial biotechnology and medical/veterinary research communities, announced today their new partnership with the University of California, San Francisco (UCSF) Cell Culture Facilities at the Parnassus and Mission Bay Campuses.

“We are very pleased to support the biomedical research laboratories at these UCSF campuses with our competitive, world-class cell culture products,” stated Stephen Judd, Axenia’s Founder and CEO. “This latest development also enhances Axenia’s prior commitments to the Howard Hughes Medical Institute (HHMI) researchers at UCSF, delivering affordable cell culture products at a time of uncertain research budgets.”

UCSF is among the world’s leading centers for health science research. Founded in 1873, with a mission to serve as a “public university dedicated to saving lives and improving health,” UCSF is unique for being the only University of California campus dedicated solely to graduate education in health and biomedical sciences.

“UCSF carries a reputation for unique and powerful interdisciplinary collaboration,” said Judd. “This enlightened atmosphere correlates well with Axenia’s culture of working together in trusted-partner relationships to extend the world’s biomedical knowledge base.”

The UCSF Parnassus Campus serves as the main campus and includes numerous research labs, the 600- bed UCSF Medical Center, Langley Porter Psychiatric Institute, and the UCSF Children’s Hospital. The Campus also includes the Schools of Dentistry, Medicine, Nursing, Pharmacy and Biomedical Sciences.

The UCSF Mission Bay Campus is the largest ongoing biomedical construction project in the world. The 43-acre Mission Bay Campus opened in 2003, with construction still ongoing, contains additional research space and facilities to foster biotechnology and life sciences companies.

“The biotechnology research community in Northern California continues to expand and mature,” stated Judd. “We are delighted that our association with the Parnassus and Mission Bay Campuses of UCSF will enable us to play a supporting role in this expansion.”